Quarterly ResultMay 8, 2026, 07:03 AM
Ultralife Q1 Net Loss ($0.03) EPS on $47.4M Revenue; Backlog $115.1M
AI Summary
Ultralife Corporation reported a net loss of ($0.03) per share on $47.4 million in revenue for Q1 2026, a 6.5% decrease year-over-year. The company experienced an operating loss of ($0.2) million, impacted by $1.7 million in one-time costs and production challenges including a power outage and inventory integration activities. Despite the financial setbacks, Ultralife achieved a record backlog of $115.1 million, reflecting long-sales cycle orders for new products. Management is focused on improving manufacturing efficiencies and driving Communications Systems orders to restore profitability and generate cash flow in 2026.
Key Highlights
- Q1 2026 Revenue was $47.4 million, a 6.5% decrease from $50.7 million in Q1 2025.
- Q1 2026 GAAP EPS was ($0.03) per share, compared to $0.11 in Q1 2025.
- Operating loss was ($0.2) million, including $1.7 million in one-time costs.
- Adjusted EBITDA was $3.2 million, down from $5.4 million in Q1 2025.
- Backlog reached a record $115.1 million, up from $110.2 million exiting Q4 2025.
- Battery & Energy Products sales decreased 4.7% to $44.2 million.
- Communications Systems sales decreased 25.7% to $3.3 million.
- Gross profit was $10.1 million (21.3% of revenue), down from $12.7 million (25.1%) YoY.